In addition, ATF3 can improve hepatic macrophage glucolipid metabolism and reduce hepatocyte steatosis depending on retinol-binding protein 4 (RBP4) in the pathogenesis of MASH (179). The gene discussed is RBP4; the disease is steatosis.